$107.70
-1.03-0.95%
At Close: -
$108.12
0.420.39%
After Hours: 9:29 AM EDT
15 minutes delayed
Comments
Loading...
Novartis
NVSNYSE
Latest news for Novartis (NYSE:NVS) Stock
Novartis Stock (NYSE: NVS)
Categories: All
Tuesday, July 23, 2024
Thursday, July 18, 2024
- VIX Stages Double-Digit Spike As Risk Off Takes Over; Chipmakers Fail To Rebound, Weight Loss Giants Eli Lilly, Novo Tumble: What's Driving Markets Thursday?
- Novartis Tops on Q2 Earnings, Ups Operating Income View
- Novartis' Q2 Earnings: Revenue And EPS Beat, Raises 2024 Profit Forecast On Strong Demand For Key Drugs
- Novartis shares are trading lower. The compan...
- Wall Street Gearing Up For Tech-Led Rebound Ahead Of Netflix Earnings: Economist Expects Soft Landing But Says Brace For Bigger Fed Rate Cuts If This Happens
- D.R. Horton, Netflix And 3 Stocks To Watch Heading Into Thursday
- Novartis Now Expects 2024 Net Sales To Grow H...
- Novartis Q2 2024 Adj EPS $1.97 Beats $1.89 Es...
Monday, July 15, 2024
Friday, July 05, 2024
Tuesday, July 02, 2024
Friday, June 21, 2024
Thursday, June 20, 2024
Wednesday, June 12, 2024
Thursday, June 06, 2024
Friday, May 31, 2024
Tuesday, May 28, 2024
Friday, May 24, 2024
Wednesday, May 22, 2024
Thursday, May 16, 2024
Friday, May 10, 2024
Wednesday, May 08, 2024
Wednesday, May 01, 2024
Tuesday, April 30, 2024
Monday, April 29, 2024
Thursday, April 25, 2024
Wednesday, April 24, 2024
Tuesday, April 23, 2024
- FDA Approves Novartis' Lutathera As First Therapy For Pediatric Patients With Gastroenteropancreatic Neuroendocrine Tumors
- Novartis Radioligand Therapy Lutathera FDA Ap...
- Stocks Rally On Weaker PMI Data, Tech Earnings Optimism, Dollar Falls: What's Driving Markets Tuesday?
- Novartis Stock Gains On European Drugmaker's Q1 Earnings Surprise, Lifts Annual Outlook
- Wall Street Set To Open Higher As Tesla Kicks Off 'Magnificent 7' Earnings: Why This Analyst Thinks Market Weakness Is A 'Healthy Pullback'
- Novartis shares are trading higher after the ...
- Novartis Now Expects 2024 Net Sales To Grow H...
- Novartis Q1 2024 Adj EPS $1.80 Beats $1.67 Es...